Corpus Callosum Atrophy Rate in Mild Cognitive Impairment and Prodromal Alzheimer's Disease

被引:28
|
作者
Elahi, Sahar [1 ]
Bachman, Alvin H. [1 ]
Lee, Sang Han [1 ]
Sidtis, John J. [1 ,2 ]
Ardekani, Babak A. [1 ,2 ]
机构
[1] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
[2] NYU, Sch Med, Dept Psychiat, New York, NY USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; brain; circularity; corpus callosum; magnetic resonance imaging; mild cognitive impairment; shape analysis; NEUROIMAGING INITIATIVE ADNI; MAGNETIC-RESONANCE; LONGITUDINAL MRI; AUTOMATIC DETECTION; EARLY-STAGE; SHAPE; SIZE; MCI; SCHIZOPHRENIA; SEGMENTATION;
D O I
10.3233/JAD-142631
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Corpus callosum (CC) size and shape have been previously studied in Alzheimer's disease (AD) with the majority of studies having been cross-sectional. Due to the large variance in normal CC morphology, cross-sectional studies are limited in statistical power. Determining individual rates of change requires longitudinal data. Physiological changes are particularly relevant in mild cognitive impairment (MCI), in which CC morphology has not been previously studied longitudinally. Objective: To study temporal rates of change in CC morphology in MCI patients over a one-year period, and to determine whether these rates differ between MCI subjects who converted to AD (MCI-C) and those who did not (MCI-NC) over an average (+/- SD) observation period of 5.4 (+/- 1.6) years. Methods: We used a novel multi-atlas based algorithm to segment the mid-sagittal cross-sectional area of the CC in longitudinal MRI scans. Rates of change of CC circularity, total area, and five sub-areas were compared between 57 MCI-NC and 81 MCI-C subjects. Results: The CC became less circular (-0.89% per year in MCI-NC, -1.85% per year in MCI-C) with time, with faster decline in MCI-C (p = 0.0002). In females, atrophy rates were higher in MCI-C relative to MCI-NC in total CC area (p = 0.0006), genu/rostrum (p = 0.005), and splenium (0.002). In males, these rates did not differ between groups. Conclusion: A greater than normal decline in CC circularity was shown to be an indicator of prodromal AD in MCI subjects. This measure is potentially useful as an imaging biomarker of disease and a therapeutic target in clinical trials.
引用
收藏
页码:921 / 931
页数:11
相关论文
共 50 条
  • [21] Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
    Park, Jung Eun
    Choi, Kyu Yeong
    Kim, Byeong C.
    Choi, Seong-Min
    Song, Min-Kyung
    Lee, Jang Jae
    Kim, Jahae
    Song, Ho-Chun
    Kim, Hoo-Won
    Ha, Jung-Min
    Seo, Eun Hyun
    Song, Woo Keun
    Park, Sung-Gyoo
    Lee, Jung Sup
    Lee, Kun Ho
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2019, 9 (01): : 100 - 113
  • [22] Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment
    Gallagher, Damien
    Coen, Robert
    Kilroy, Dana
    Belinski, Kate
    Bruce, Irene
    Coakley, Davis
    Walsh, Bernard
    Cunningham, Conal
    Lawlor, Brian A.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (02) : 166 - 172
  • [23] The role of multimodal MRI in mild cognitive impairment and Alzheimer's disease
    Knudsen, Laust Vind
    Gazerani, Parisa
    Michel, Tanja Maria
    Vafaee, Manouchehr Seyedi
    JOURNAL OF NEUROIMAGING, 2022, 32 (01) : 148 - 157
  • [24] Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease
    Persson, Karin
    Barca, Maria Lage
    Eldholm, Rannveig Sakshaug
    Cavallin, Lena
    Benth, Jurate Saltyte
    Selbaek, Geir
    Braekhus, Anne
    Saltvedt, Ingvild
    Engedal, Knut
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2017, 44 (1-2) : 12 - 24
  • [25] Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers
    Marizzoni, Moira
    Ferrari, Clarissa
    Jovicich, Jorge
    Albani, Diego
    Babiloni, Claudio
    Cavaliere, Libera
    Didic, Mira
    Forloni, Gianluigi
    Galluzzi, Samantha
    Hoffmann, Karl-Titus
    Molinuevo, Jose Luis
    Nobili, Flavio
    Parnetti, Lucilla
    Payoux, Pierre
    Ribaldi, Federica
    Rossini, Paolo Maria
    Schoenknecht, Peter
    Salvatore, Marco
    Soricelli, Andrea
    Hensch, Tilman
    Tsolaki, Magda
    Visser, Pieter Jelle
    Wiltfang, Jens
    Richardson, Jill C.
    Bordet, Regis
    Blin, Olivier
    Frisoni, Giovanni B.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (01) : 3 - 14
  • [26] Cognitive Decline in Adults with Amnestic Mild Cognitive Impairment and High Amyloid-β: Prodromal Alzheimer's Disease?
    Lim, Yen Ying
    Ellis, Kathryn A.
    Harrington, Karra
    Pietrzak, Robert H.
    Gale, Joanne
    Ames, David
    Bush, Ashley I.
    Darby, David
    Martins, Ralph N.
    Masters, Colin L.
    Rowe, Christopher C.
    Savage, Greg
    Szoeke, Cassandra
    Villemagne, Victor L.
    Maruff, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (04) : 1167 - 1176
  • [27] Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
    Deters, Kacie D.
    Shannon, L. Risachera
    Kim, Sungeun
    Nhoa, Kwangsik
    West, John D.
    Blennow, Kaj
    Zetterberge, Henrik
    Shaw, Leslie M.
    Trojanowski, John Q.
    Weiner, Michael W.
    Saykin, Andrew J.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (04) : 1245 - 1254
  • [28] Olfactory memory in mild cognitive impairment and Alzheimer's disease
    Audronyte, Egle
    Sutnikiene, Vaiva
    Pakulaite-Kazliene, Gyte
    Kaubrys, Gintaras
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [29] Brain imaging of mild cognitive impairment and Alzheimer's disease
    Changhao Yin
    Siou Li
    Weina Zhao
    Jiachun Feng
    Neural Regeneration Research, 2013, 8 (05) : 435 - 444
  • [30] Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia
    Tomimoto, H
    Lin, JX
    Matsuo, A
    Ihara, M
    Ohtani, R
    Shibata, M
    Miki, Y
    Shibasaki, H
    JOURNAL OF NEUROLOGY, 2004, 251 (04) : 398 - 406